Features | Partner Sites | Information | LinkXpress
Sign In

Fluke Biomedical Acquires Unfors RaySafe

By Medimaging International staff writers
Posted on 06 Feb 2014
Fluke Biomedical (Everett, WA, USA), a world-leading manufacturer of biomedical test instruments, has reported that it has acquired Unfors RaySafe (Billdal, Sweden), a company that develops X-ray dose monitoring technology.

With this acquisition, Fluke Biomedical adds industry leading quality assurance devices for diagnostic X-ray from Unfors RaySafe. With an optimized product range in the fields of diagnostic X-ray, real-time dose monitoring systems for medical personnel and patient dose tracking software, the Unfors RaySafe product line will expand the Fluke Biomedical customer base and answer market needs with novel technology. Fluke Biomedical’s goal is to provide healthcare providers, institutions, and medical device manufacturers with a complete range of test equipment.

Both companies note the user friendliness of their products, combined with sophisticated technology and optimal measurement accuracy as their major strengths. “The fact that our companies share a similar culture is an ideal basis for continuing our excellent relationships with our employees, customers and partners,” said Magnus Kristoferson, CEO of Unfors RaySafe. “We have experience in highly specialized markets all over the world, we know our business, and we can now maximize our competencies. In the past, Unfors RaySafe has attracted the attention of the market not just for the functionality and measurement accuracy of its products, but also for the attractive design and intuitive user interface.”

Fluke Biomedical manufactures biomedical test and simulation products, including electrical safety testers, patient simulators, performance analyzers, and fully integrated and automated performance testing and documentation systems. Fluke Biomedical general manager, Eric Conley stated, “The acquisition of Unfors RaySafe brings to Fluke Biomedical a strong team that has delivered leading innovation to the radiation test and safety markets. The combination of Unfors RaySafe and Fluke Biomedical accelerates our ability to provide a broad portfolio of world class test equipment to our customers.”

Fluke Biomedical anticipates, with worldwide sales and distribution channels, growth through innovative design and creative solutions for their customers.

Fluke Biomedical is a global provider of test and measurement equipment and services to the healthcare industry. The company serves biomedical engineers, quality-assurance technicians, medical physicists, oncologists and radiation-safety professionals, and are continually expanding their range of solutions to a broader range of health and safety professionals. Fluke Biomedical is part of Fluke Corp., a leader in the manufacture, distribution, and service of electronic test tools and software.

Unfors RaySafe offers a solution for the X-ray room consisting of devices for quality assurance and service of diagnostic X-ray units, real-time dose monitoring for medical staff, and patient dose-tracking software. All products combine user-friendliness with innovative technology to help technicians, medical staff, and patients avoid unnecessary radiation exposure. Unfors RaySafe has offices in the United States, United Kingdom, Germany, Singapore, India, Japan, and China, as well as with a closely connected sales network, Unfors RaySafe serves a global customer base that includes leading manufacturers of X-ray machines and university hospitals worldwide.

Related Links:

Fluke Biomedical
Unfors RaySafe

SuperSonic Imagine



view channel

Leading Cancer Center Among First in Europe to Treat Patients Using Robotic Patient-Positioning Radiotherapy Couch

A Viennese hospital has become one of the first oncology departments in Europe to introduce clinical treatments using a robotic radiotherapy patient-positioning couch. Kaiser-Franz-Josef Hospital (KFJ; Vienna, Austria) has introduced this enhanced patient positioning device, which enables more flexibility during radiotherapy... Read more


view channel

Use of Breast MRI Offers Optimized Care

Magnetic resonance imaging (MRI) is being used increasingly for breast cancer screening, diagnostic assessment, treatment planning, and monitoring; however, a recent study revealed that over time, the indication for breast MRI has changed. Much of the increase was found among women with breast cancer risk factors, but there... Read more


view channel
Image: Analogic Sonic Window handheld ultrasound for peripheral IV placement (Photo courtesy of Analogic).

First-of-a-Kind Ultrasound System Designed for Image-Guided Peripheral Intravenous Access and Fits in Pocket

A new, ultra-compact ultrasound device provides direct visualization of structures beneath the skin in real time to effectively guide clinicians placing peripheral intravenous (IV) lines.... Read more

Nuclear medicine

view channel
Image: Micrograph of Hodgkin lymphoma. Lymph node fine-needle aspiration (FNA) specimen. Field stain (Photo courtesy of Wikimedia Commons).

Early PET-Negative Stage I/II Hodgkin Lymphoma Patients Show Increased Risk of Early Relapse when Radiotherapy Is Not Used

Analysis of a new study indicates an increased risk of early relapse when excluding radiotherapy in early positron emission tomography (PET) scan-negative patients with stage I/II Hodgkin’s lymphoma.... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Enterprise Image-Viewing System Receives FDA Clearance for Mobile Diagnosis on All Modalities

An enterprise image-viewing system is now cleared in the United States for diagnosis on mobile devices, for all imaging modalities (except mammography). Calgary Scientific, Inc. (Calgary, AB, USA) recently reported their latest Class II clearance from the US Food and Drug Administration (FDA). Calgary Scientific worked... Read more
Copyright © 2000-2014 Globetech Media. All rights reserved.